Factors Affecting Response to Extracorporeal Shock Wave Therapy in Plantar Fasciitis: A Cross-sectional Clinical Study
Launched by SISLI HAMIDIYE ETFAL TRAINING AND RESEARCH HOSPITAL · May 27, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Plantar heel pain is one of the reasons that affect daily life activities. There are many treatment methods for this. Extracorporeal shock wave therapy (ESWT) is one of them. However, some patients do not respond to ESWT treatment. In this study, patients were divided into 2 groups as those who did not respond to ESWT treatment in terms of pain (less than 50% decrease in pain level) or those with recurrence of pain and those who responded to treatment. Patients who had passed 3-6 months after ESWT constituted the study groups. These two groups will be compared in terms of age, gender, occup...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years
- • Unresponsive to conservative treatments (physical therapy, rest, exercises, anti-inflammatory medical treatment, insoles, etc.)
- • Patients who have received ESWT treatment and 3-6 months have passed since ESWT
- Exclusion Criteria:
- • History of injection therapy including steroids after ESWT treatment
- • Those taking NSAIDs in the last 2 weeks
- • Those with a history of trauma or surgery to the foot or ankle
- • Presence of rheumatic disease affecting the foot or ankle (e.g. spondyloarthritis, etc.)
- • Malignancy
- • Pregnancy
About Sisli Hamidiye Etfal Training And Research Hospital
Sisli Hamidiye Etfal Training and Research Hospital is a prominent healthcare institution dedicated to advancing medical research and education. Located in Istanbul, Turkey, the hospital is affiliated with the Ministry of Health and serves as a leading center for clinical trials, providing comprehensive services in various medical specialties. With a strong commitment to improving patient outcomes and contributing to scientific knowledge, Sisli Hamidiye Etfal fosters collaboration among healthcare professionals, researchers, and academic institutions. The hospital is equipped with state-of-the-art facilities and adheres to the highest ethical standards, ensuring the integrity and safety of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, , Turkey
Patients applied
Trial Officials
Banu Kuran, Professor, MD
Study Director
Şişli Hamidiye Etfal Taining and Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported